Skip to main content
Hit enter to search or ESC to close
Search
Close Search
Menu
Company
Team
Psybrary™
Pipeline
Investors
Investor Overview
Press Releases
Media Coverage
Events + Presentations
Stock Information
SEC Filings
Corporate Governance
News Alerts
Contact
twitter
facebook
linkedin
Investors
Press Releases
NASDAQ: ENVB
Overview
Press Releases
Media Coverage
Events + Presentations
Stock Information
SEC Filings
Corporate Governance
News Alerts
Press Releases
Enveric Biosciences Launches Development Collaboration and Supply Agreement with PureForm Global to Support Cannabinoid Clinical Programs
February 25, 2021
Enveric Biosciences Inc. Announces Closing of $12.8 Million Registered Direct Offering of Common Stock
February 12, 2021
Enveric Biosciences Inc. Announces $12.8 Million Registered Direct Offering
February 9, 2021
Enveric Biosciences Issues Shareholder Letter Providing Strategic Vision for Advancing Novel Prescription Supportive Care Cancer Therapies
January 19, 2021
Enveric Biosciences Inc. Announces Closing of $10 Million Registered Direct Offering
January 15, 2021
Enveric Biosciences Inc. Announces $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
January 12, 2021
Enveric Biosciences Appoints Dr. Marcus Schabacker to Board of Directors
January 5, 2021
‹
1
…
18
19
20
Close Menu
Company
Team
Psybrary™
Pipeline
Investors
Investor Overview
Press Releases
Media Coverage
Events + Presentations
Stock Information
SEC Filings
Corporate Governance
News Alerts
Contact
twitter
facebook
linkedin